Covid 19 Notifiable PIDsr PDF

AO 2020-0013
Revision to AO 2020-0012 Listing

COVID-19 as a Notifiable Disease
dated April 9, 2020
April 13, 2020
Epidemiology Bureau
04/13/2020 1
Department of Health, Philippines
Comparison of AO 2020-0012 and AO
2020-0013
Provisions AO 2020-0012 AO 2020-0013
Nomenclature PUI Suspect, probable, and confirmed COVID-19
PUM case
Close contact
Case Definitions Decision tools issued by DOH Adapted from WHO Global Surveillance
as per advice of TAG Guidelines with vetting from WHO, TAG, and
other experts
Case Detection Ports of entry More emphasis on utilizing and expanding
Health facilities SARI and ILI sentinel sites but still include all
other health facilities; Inclusion of laboratory
facilities, community quarantine and isolation
facilities
Recording and Reporting Reporting template Revised COVID-19 CIF
Forms and Database (COVID CIF, ODK) COVID-19 Information System
Management
Epidemiology Bureau
04/13/2020 2
Epidemiology Bureau
04/13/2020 3
Epidemiology Bureau
04/13/2020 4
Objectives
1. Establish a standardized mechanism of case detection, laboratory confirmation,
and notification among existing surveillance systems and among the
Epidemiology Bureau (EB), regional and local epidemiology and surveillance
units, sentinel, non-sentinel, and laboratory facilities in terms of case definition,
epidemiologic investigation, laboratory sample collection and confirmation,
notification, and feedback;
2. Establish epidemiological, clinical, and virologic characteristics of COVID-19;
3. Characterize areas as to status of local and community transmission; and
4. Generate data as the basis for informed policy and intervention measures to
contain and mitigate the spread of COVID-19
Epidemiology Bureau
04/13/2020 5
Scope and Coverage
• ALL individuals, health facilities and offices (public and
private), national and sub-national laboratories, other
laboratory facilities, civil society organizations,
professional/medical/paramedical societies, and international
organizations/donors/partners involved in disease surveillance;
• Mandatory reporting of notifiable diseases and health events of
public health concern
Epidemiology Bureau
04/13/2020 6
General Guidelines
1. Coronavirus Disease 2019 (COVID-19) is a notifiable disease as per Administrative Order No.
2020-0012 dated March 17, 2020 and its reporting shall be mandatory.
2. The COVID-19 Surveillance shall utilize existing surveillance systems, such as the ILI and SARI
surveillance systems and the Event-based Surveillance and Response System, for detection of
COVID-19 cases.
3. All DOH hospitals and level three (3) private hospitals and medical centers and health offices of
highly urbanized cities shall serve as the sentinel reporting sites for COVID-19
surveillance. Cases seen at non-sentinel hospitals and health centers and results of COVID-19
tests done at laboratory facilities shall also be mandatorily reported.
4. Case definitions for COVID-19 shall be used to ensure proper classification and appropriate
management of cases.
5. Laboratory confirmation for COVID-19 remains essential in determining the true burden of this
disease.
Epidemiology Bureau
04/13/2020 7
Sources of Information
1. SARI Surveillance
2. ILI Surveillance
3. Notification from Health Facilities and Laboratory Facilities
4. Event-based Surveillance
Epidemiology Bureau
04/13/2020 8
Case Definitions
Epidemiology Bureau
04/13/2020 9
WHO Global Surveillance Guidelines
March 20, 2020
• Case and contact definitions are based on the current available
information and are regularly revised as new information
accumulates.
• Countries may need to adapt case definitions depending on
their local epidemiological situation and other factors.
• All countries are encouraged to publish definitions used online
and in regular situation reports, and to document periodic
updates to definitions which may affect the interpretation of
surveillance data.
Epidemiology Bureau
04/13/2020 10
March 20, 2020
Epidemiology Bureau
04/13/2020 11
March 20, 2020
*Not adapted
Epidemiology Bureau
04/13/2020 12
Transition from the Old to the New
Classification for COVID-19
OLD CLASSIFICATION NEW CLASSIFICATION
Neither a Person Under Monitoring (PUM) Not a COVID-19 Case
or Patient Under Investigation
PUM Not included in the new classification
PUI (mild, severe, or critical) who was not Suspect
tested or awaiting test results
PUI (mild, severe, or critical) with Probable
inconclusive test results
COVID Positive Confirmed
Epidemiology Bureau
04/13/2020 13
Case Definitions
Severe Acute Respiratory Infection (SARI)
An acute respiratory illness with onset during the previous 7 days
requiring overnight hospitalization. A SARI case should meet the
ILI case definition AND any one of the following: (a) shortness of
breath or difficulty of breathing, (b) severe pneumonia of
unknown etiology, acute respiratory distress, or severe
respiratory disease possibly due to novel respiratory pathogens
(such as COVID-19).
Epidemiology Bureau
04/13/2020 14
Case Definitions
Influenza-like Illness (ILI)
A condition with sudden onset (within 3 days of presentation and
fever should be measured at the time of presentation) of fever of
≥38°C and cough or sore throat in the absence of other
diagnoses
Epidemiology Bureau
04/13/2020 15
Suspect COVID-19 Case Definition
1. All SARI cases where NO other etiology fully explains the clinical presentation
2. ILI cases with any one of the following:
a. With no other etiology that fully explains the clinical presentation AND a history of travel to or
residence in an area that reported local transmission of COVID-19 disease during the 14
days prior to symptom onset OR
b. With contact to a confirmed or probable case of COVID-19 in the two days prior to onset of
illness of the probable/confirmed COVID-19 case until the time the probable/confirmed
COVID-19 case became negative on repeat testing.
3. Individuals with fever or cough or shortness of breath or other respiratory signs or symptoms
fulfilling any one of the following conditions:
a. Aged 60 years and above
b. With a comorbidity
c. Assessed as having a high-risk pregnancy
d. Health worker
Epidemiology Bureau
04/13/2020 16
Probable COVID-19 Case Definition
Suspect COVID-19 case:
1. Whom testing for COVID-19 is inconclusive OR
2. Who tested positive for COVID-19 but whose test was not
conducted in a national or subnational reference laboratory or
officially accredited laboratory for COVID-19 confirmatory
testing
Epidemiology Bureau
04/13/2020 17
Confirmed COVID-19 Case Definition
Any individual, irrespective of presence or absence of clinical
signs and symptoms, who was laboratory confirmed for COVID-
19 in a test conducted at the national reference laboratory, a
subnational reference laboratory, and/or DOH-certified laboratory
testing facility.
Epidemiology Bureau
04/13/2020 18
List of Officially Accredited Laboratory
Facilities
Epidemiology Bureau
04/13/2020 19
March 20, 2020
Epidemiology Bureau
04/13/2020 20
Epidemiology Bureau
04/13/2020 21
For Reporting
1. Aggregated data of ILI cases weekly – identify clustering,
sudden increase of cases
2. Clustering or sudden increase of ILI or SARI cases and
deaths of unknown etiology – report via event-based
surveillance
Epidemiology Bureau
04/13/2020 22
Clustering
1. 3 or more confirmed COVID -19 cases reported over two
consecutive weeks who:
a. Were from the same workplace
b. Passengers/Crew of same flight, sea vessel, bus, and other
transportation service
c. Attended the same event or social gathering
2. 3 or more households with at least one household member who is
a confirmed COVID-19 case located in the same barangay (highly
urbanized city) or municipality/component city
3. 3 or more residential units with at least one household member
who is a confirmed COVID-19 case in the same residential
building
Epidemiology Bureau
04/13/2020 23
Epidemiology Bureau
04/13/2020 24
Sentinel Sites
1. SARI Surveillance Sentinel Sites
• Baguio General Hospital
• San Lazaro Hospital
• Research Institute for Tropical Medicine
• Vicente Sotto Memorial Medical Center
• Southern Philippines Medical Center
• Level III and DOH hospitals and medical centers*
2. ILI Surveillance Sentinel Sites
• 18 ILI sentinel sites
• Highly urbanized cities*
*Expansion sites
Epidemiology Bureau
04/13/2020 25
Other Reporting Units
• Other health facilities (hospitals, health centers)
• Laboratory facilities
• Community quarantine and isolation facilities*
*Included in Joint AO between DOH and DILG
Epidemiology Bureau
04/13/2020 26
Epidemiology Bureau
04/13/2020 27
Epidemiology Bureau
04/13/2020 28
Epidemiology Bureau
04/13/2020 29
Epidemiology Bureau
04/13/2020 30
Epidemiology Bureau
04/13/2020 31
Awaiting official approval
Epidemiology Bureau
04/13/2020 32
Daily Monitoring
1. Medical Status (of condition, as of time of update), including
current signs and symptoms
2. Laboratory Status
3. For fatalities:
a. Date and Time of Death
b. Cause of Death
c. Comorbidities
4. Disposition
5. Remarks: any other relevant notes from the patient chart; indicate
especially if the patient is using a ventilator.
Epidemiology Bureau
04/13/2020 33
Name of Reporting Hospital: ___________________________________________________
Address: ___________________________________________________________________
Total Number of Admissions: _________
• No. Suspect Cases: ___________
• No. Probable Cases: __________
• No. Confirmed Cases: ________
Name of Patient Medical Status Laboratory If DEATH, fill in the following information Disposition Remarks
Update and Status (Discharged,
Current Date and Cause of Death List of DAMA, HAMA,
(Positive, (Intubated, On
Significant Signs Time of Death Comorbidities Absconded,
Negative, ventilator, etc.)
and Symptoms Transferred; if
Equivocal, transferred,
(Asymptomatic, Pending) indicate which
Mild, Severe, facility)
Critical, Death)
Epidemiology Bureau
04/13/2020 34
Name of Laboratory Facility: ____________________________________________________________________
Address: ____________________________________________________________________________________
Name Age Sex Name of Type of Type of Date Specimen Date Date Results Test
(Last Name, Requesting Laboratory Specimen Collected Specimen Released Results
First Name, Facility Facility: SNL, (NPS, OPS, (mm/dd/yyyy) Received (mm/dd/yyyy)
Middle Name) Non-SNL Serum, Etc.) (mm/dd/yyyy)
Epidemiology Bureau
04/13/2020 35
COVID-19 Information
System
Epidemiology Bureau
04/13/2020 36
Epidemiology Bureau
04/13/2020 37
Updates on COVID-19
Information System to be
discussed after this presentation
Epidemiology Bureau
04/13/2020 38
Epidemiology Bureau
04/13/2020 39
Roles and Responsibilities
Epidemiology Bureau
04/13/2020 40
Epidemiology Bureau
1. Lead in the establishment and implementation of the COVID-19 Surveillance System.
2. Draft and issue required policies and guidance in relation to this surveillance system.
3. Conduct training, orientation, and/or technical assistance to ensure that disease
reporting units and concerned stakeholders will know how to implement the system.
4. Shall be the process owner of the COVID-19 Information System and as such shall:
• Act as the Database Managers for surveillance data
• Liaise with the COVID-19 coordinators for the timely turnover of complete data and
information
• Review and approve updated attribute data which may be submitted by the users
5. Draft and disseminate COVID-19 surveillance report.
6. Assess and coordinate with respective RESUs all reported clustering, sudden increase,
and local transmission of COVID-19 within 24 hours upon receipt of detection of
clustering, sudden increase, or local transmission.
Epidemiology Bureau
04/13/2020 41
Epidemiology Bureau
6. When necessary, provide support through technical staff and logistic assistance during
epidemiologic investigation and response.
7. Oversee the design of appropriate reporting software for the inclusion of COVID-19 into
the SARI/ILI, existing hospital sentinel surveillance and/or information system, and
community-based disease surveillance system.
8. Facilitate dissemination of related information, policies, and recommendations from DOH
Central Office and the World Health Organization (WHO) to the concerned agencies and
institutions.
9. Allocate funds for the operation of the COVID-19 surveillance system.
10.Monitor the implementation of the system.
11.Notify the WHO as part of International Health Regulations commitment
Epidemiology Bureau
04/13/2020 42
Regional Epidemiology and
Surveillance Units
Assume the roles and responsibilities of EB at the regional level
1. Lead in the establishment and implementation of the COVID-19 Surveillance System at the regional
level.
2. Identify strategies and activities to operationalize the surveillance system at their level and at local
health offices and disease reporting units.
3. Conduct data verification of submitted CIF and/or records and reports encoded in the COVID-19
Information System.
4. Conduct training, orientation, and/or technical assistance to ensure that disease reporting units and
concerned stakeholders will know how to implement the system.
5. Prepare and disseminate COVID-19 surveillance report.
6. Disseminate related information, policies, and recommendations from DOH Central Office and the
World Health Organization (WHO) to the health facilities, disease reporting units, and concerned
agencies and institutions at their level.
7. Allocate funds for the COVID-19 surveillance system.
8. Monitor the implementation of the system.
Epidemiology Bureau
04/13/2020 43
Bureau of Quarantine
1. Conduct surveillance in ports and airports of entry and sub-ports as well as the airports
and ports of origin of international flights and vessels.
2. Collect completed health declaration cards and enter into the database management
system.
3. Perform entry screening and preliminary investigation of all suspected cases identified in
all ports of entry and exit.
4. Provide the passenger manifest and other relevant information to EB and/or RESU for
case investigation and contact tracing.
6. Monitor public health threats in other countries.
Epidemiology Bureau
04/13/2020 44
National Reference Laboratory (Research
Institute for Tropical Medicine)
1. Allocate funds for laboratory testing for COVID-19 and other SARI pathogens.
2. Allocate funds to support quality assurance activities of sub-national and other
laboratories
3. Provide confirmatory services to COVID-19 cases.
4. Provide funds and technical support for specimen collection, transport, and
storage from the sites to the laboratory.
5. Provide technical support, training, and quality assurance to the subnational
laboratories and officially accredited laboratory testing facilities.
6. Assess testing facilities for accreditation as an official laboratory confirmatory
testing facility.
7. Provide laboratory results to designated DOH officials, EB, RESU, and health
facilities and disease reporting units.
Epidemiology Bureau
04/13/2020 45
Subnational Reference Laboratories and
DOH-Certified Laboratory Testing
Facilities
1. Provide confirmatory services to suspect COVID-19 cases.
2. Provide laboratory results to DOH and its identified officials
and offices and requesting health facilities.
Epidemiology Bureau
04/13/2020 46
Field Implementation and Coordination Team,
Centers for Health Development, Health Facility and
Services Regulatory Bureau, and PhilHealth
1. Assist EB and RESU in ensuring compliance of health
facilities, health providers, and laboratory facilities, both
government and private, to guidelines for recording,
investigation, and notification of suspect, probable, and
confirmed COVID-19 cases
2. Assist the DOH Database Managers in following up and
ensuring the timely submissions of government and private
health facilities, health providers, and laboratory facilities
Epidemiology Bureau
04/13/2020 47
Knowledge Management and Information
Technology Service (KMITS)
1. Lead the development and implementation of the COVID-19
Surveillance System such that it is capable of interconnection,
interoperation and/or integration with various data networks and
solutions related to COVID-19 surveillance.
2. Undertake appropriate monitoring and evaluation activities to ensure
quality of system implementation, including adequacy of control
mechanisms, data quality and security management, and feedback
system.
3. Resolve technical issues and concerns related to the development,
implementation, and use of the surveillance system.
Epidemiology Bureau
04/13/2020 48
Provincial and City/Municipal Health
Offices
1. Orient and or re-orient hospital staff on mandatory disease reporting
requirements
2. Support the operation of the epidemiology and surveillance unit through
the following:
a. Identify and designate health staff to be trained and assigned as the COVID-19
Coordinator
b. Assign a staff for data encoding and a dedicated table top computer and other IT
requirements such as internet connection for reporting are available.
c. Allocate budgetary support through the incorporated in the annual work and
financial plan of the provincial/city/municipal health office the operation of the
ESU for effective disease surveillance system
Epidemiology Bureau
04/13/2020 49
Local (Provincial, City, and Municipal)
Epidemiology and Surveillance Units
1. Lead in the investigation, validation, contact tracing, monitoring of
reported cases of COVID-19, and other response activities. This includes
investigation of reported clustering cases.
2. Conduct training, orientation, and/or technical assistance to public health
associates (PHAs) and barangay health emergency response teams
(BHERTs) on case identification, close contact monitoring, and reporting
of persons under quarantine, underscoring the importance of mandatory
disease reporting requirements for COVID-19 surveillance.
3. Operationalize the surveillance system at their level
4. Allocate funds for the operation of the COVID-19 surveillance and
response
Epidemiology Bureau
04/13/2020 50
Health Facilities and Disease
Reporting Units
1. Orient or re-orient hospital/health facility staff regarding mandatory disease reporting
requirements for COVID-19 surveillance.
2. Designate disease surveillance coordinators who will be responsible for preliminary
investigation of suspect cases seen at the hospital.
3. Designate an COVID-19 coordinators, ideally the Hospital Epidemiology and
Surveillance Unit or Infection Prevention and Control Head or Point Persons, who shall
be responsible in: (a) ensuring completion and submission of CIF and/or encoding
using the COVID-19 Information System, (b) ensuring laboratory sample collection and
transport, (c) receive laboratory results, and (d) disclose laboratory results to attending
physicians and/or case.
4. Assign a dedicated encoder and provide IT requirements for recording and notification.
Epidemiology Bureau
04/13/2020 51
Health Facilities and Disease
Reporting Units
5. Coordinate with EB and RESU, especially during case investigation and
close contact tracing.
6. Provide access to medical records, facilitate case interviews, and other
case investigation and contact tracing activities.
7. Provide daily updates to RESU as to case status of admitted suspect,
probable, or confirmed cases using prescribed template.
Epidemiology Bureau
04/13/2020 52
Separability/Repealing Clause
Administrative Order No. 2020-0012 dated March 17, 2020
entitled “Guidelines for the Inclusion of the Coronavirus Disease
2019 (COVID-19) in the List of Notifiable Diseases for Mandatory
Reporting to the Department of Health” and all other issuances
inconsistent with this Order are hereby repealed, rescinded,
amended or modified accordingly.
Epidemiology Bureau
04/13/2020 53
Effectivity
This Order shall take effect immediately.
Epidemiology Bureau
04/13/2020 54
Steps in Contact Tracing for
LGUs
(backward tracing)
Epidemiology Bureau
04/13/2020 55
In Public Health, Contact Tracing is
• the process of identification of persons who may have come
into contact with an infected person ("contacts") and
subsequent collection of further information about these
contacts
• by tracing the contacts of infected individuals, testing them for

infection, treating the infected and tracing their contacts in turn,
public health aims to reduce infections in the population
Epidemiology Bureau
04/13/2020 56
Goals of Contact Tracing
• To interrupt ongoing transmission and reduce spread of an infection
• To alert contacts to the possibility of infection and offer preventive
counseling or prophylactic care
• To offer diagnosis, counseling and treatment to already infected
individuals
• If the infection is treatable, to help prevent re-infection of the
originally infected patient
• To learn about the epidemiology of a disease in a particular
population
Epidemiology Bureau
04/13/2020 57
Ethical and Legal Issues
Privacy and duty to warn
• Public health practitioners often have legal requirements to act to
contain a communicable disease within a broader population and also
cite an ethical duty to warn individuals of their exposure.
• Simultaneously, infected individuals have a recognized right to medical

confidentiality.
• Public health teams typically disclose the minimum amount of

information required to achieve the objectives of contact tracing
Epidemiology Bureau
04/13/2020 58
Ethical and Legal Issues
Confidentiality and Risk of Stigma
Fear of loss of confidentiality and subsequent stigma,
discrimination, or abuse as a result of contact tracing that may
discourage persons from seeking medical treatment
Note: Public health officials have recognized that the goals of

contact tracing must be balanced with maintenance of trust with
vulnerable and sensitivity to individual situations
Epidemiology Bureau
04/13/2020 59
Who is a Close Contact? Date when
Date when confirmed case first had confirmed
a sign or symptom case
(Fever, cough, respiratory signs REPEAT
and symptoms) TEST is
OR tested positive (if NEGATIVE
asymptomatic)
2 days before
onset
0 XX Days after onset of illness
Close Contacts:
Individuals who cared for, lived, worked, travelled, and transacted with confirmed
COVID-19 case during this time period
Epidemiology Bureau
04/13/2020 60
Close Contact Categories and Definitions
Category Definition
This includes passengers of a flight or sea vessel, bus, train, or other transportation/vehicle
A whose seat is located four rows in front, at the back, or at any side of a confirmed case who
is still in the Philippines
This includes passengers of a flight or sea vessel, bus, train, or other transportation/vehicle
B whose seat is located four rows in front, at the back, or at any side of a confirmed case who
had already left the Philippines
This includes persons who have had exposure when they lived with, worked with*,
transacted with*, or cared for a confirmed case.
C *WHO has recommended that this will include individuals who had a face-to-face contact
with a confirmed case for at least a 15-minute conversation within one meter from the
confirmed case OR was shared an enclosed space for a minimum of two (2) hours with a
confirmed case.
This includes passengers or crew of vehicles/vessels taken/used by, and persons who lived
D with, worked with, transacted with, or cared for a suspect who died during their 14-day
monitoring period
Epidemiology Bureau
04/13/2020 61
6 Major Steps in Contact Tracing
1. Identify the confirmed COVID-19 case (confirmed case). This case will be reported to the primary health care
facility.
2. Interview the confirmed case to learn about their movements, whom they have been in close contact 2 days
prior to the onset of signs and symptoms up to the time the confirmed case’s laboratory test yielded negative
result.
3. Identify individuals who cared for, lived, worked, travelled, and transacted with a confirmed case are
considered as CLOSE CONTACTS.
4. Contact all close contacts for an interview and to offer medical counseling. If a close contact is sick at the time
of the interview, assess if close contact shall fir COVID-19 case definitions and refer for laboratory testing and
management, as per guideline.
5. Isolate sick close contacts (e.g. required to remain at home or referred to a health facility or a hospital).
6. If contacts are not individually identifiable (e.g. members of the public who attended the same location),
broader communications may be issued, like media advisories.
Epidemiology Bureau
04/13/2020 62
Case Investigation Process 1. List of cases at home
requiring facility
isolation
2. Refer to appropriate
isolation health facility
1. Profile the case NO after clinical
Submit to the assessment
2. Assess for Contact Tracing
Confirmed presence of sign and Monitoring Case is in 3. Commence contact
COVID-19 or symptom Team completed a health tracing by
Case case profile and facility? designated team
3. Identify and list close contact line
close contacts list
and contact YES
information Commence contact
tracing by designated
team
*Algorithm for close contact definition, assessment,
testing and referral in following slides
Local Government Unit

DOH-CHD Local Epidemiology and Surveillance Contact Tracing and Monitoring Team
Epidemiology Bureau
04/13/2020 63
63
Unit
Contact Tracing Team
• Team Leader: City or Municipal PNP Chief
• Co-Lead: City or Municipal Health Officer
• Secure the list of local COVID-19 cases from regional DILG
• Lead in drafting plan for case investigation
• Identify location of cases
• Secure the area where case is located
• Members: City or Municipal Philippine National Police; physicians, nurses, midwives,

and/or sanitary inspectors from the City or Municipal Health Office, Bureau of Fire
Protection, City or Municipal Disaster Risk Reduction and Management Office, Barangay
Health Emergency Response Team
• Conduct contact tracing: profile and assess close contacts
• Collect laboratory samples, as needed
• Conduct immediate transport of close contacts for health facility isolation
• Provide health education and give instructions about what they need to do
• Submit accomplished forms to City/Municipal Health Officer and the City/Municipal Epidemiology
and Surveillance Unit
Epidemiology Bureau
04/13/2020 64
Contact Tracing Process at the local level
Assess for the
Reported ONLY Home-based
Identify following: PNP with Local Quarantine and for
Confirme Health Authorities
contact 1.Presence of daily monitoring
d COVID- s (ESU) generate
YES sign or
19 Case the list of close
symptom
2.Identify if contacts, locate Home-based Quarantine
Close contact is a them, further +
Contac COVID-19 Testing
health worker identify and
t? profile other close
contacts and Health Facility
Provide classify as Isolation
information on +
follows:
NO infection COVID-19 Testing
prevention and
*Algorithm for close contact definition, assessment,
control
testing and referral in following slides
DOH- Contact Tracing Team

CHD Local Government Unit
Epidemiology Bureau
04/13/2020 65
65
Epidemiology Bureau
04/13/2020 66
Close Contact Line list Form
Confirmed Case ID: ______________________________________________________________
Onset of Illness of Confirmed COVID-19 Case (mm/dd/yyyy): ______________________________
Epidemiology Bureau
04/13/2020 68
Functions of the Close Contact and
Monitoring Team
Team Leaders: City or Municipal PNP Chief and City or
Municipal Health Officer
1. Reports to the Local Executives
2. Organize and deployed local contact tracing teams
3. Listing of close contacts endorsed for close contact tracing and
monitoring
4. Prepare and provide needed logistic for contact tracings and
monitoring such as forms, communication allowance, thermometer,
PPE, etc.
5. Coordinate with appropriate barangay officials
6. Ensures that reports are submitted on time at the Regional DILG and
RESU of the Center for Health Development
Epidemiology Bureau
04/13/2020 69
Functions of the Close Contact
Monitoring Team
Members:
A. PNP, City/Municipal or Rural Health Physicians, Nurses or
Midwives, BHERTS
1. Conduct daily monitoring of close contacts for 14 days
2. Accomplish recording forms and submit to health office at the end of each
day
3. Facilitate transport for immediate referral of contacts who are symptomatic
for appropriate assessment and management
4. Provide health education and give instructions about what they need to do
5. Refer to appropriate offices non-health concerns/issues of close contacts
6. Submit accomplished forms to local health office
Epidemiology Bureau
04/13/2020 70
Functions of the Epidemiology and Surveillance
Officer in Contact Tracing and Monitoring
1. Orient team members how to conduct contact tracing and monitoring;
and, use of recording forms
2. Oversee/supervise the Contact tracing and Monitoring Activities
3. Profile the reported COVID-19 case and generate line list of close
contacts
4. Endorse profile and list of close contacts to the Contact Tracing and
Monitoring Team
5. Consolidate all report forms for submission to the RESU every 5PM daily
6. Encode collected case and close contact profiled and daily monitoring
data using the COVID-19 Information System
7. Do local analysis and interpretation of local data
8. Submit report to the City/Municipal Health Officer for local dissemination
Epidemiology Bureau
04/13/2020 71
Epidemiology Bureau
04/13/2020 72
Isolation Recommendations
Asymptomatic Symptomatic
Should ideally be in a Did not fit COVID-19 Fit COVID-19 Case

quarantine facility case definition Definition
If on Home-based
Quarantine, ensure Self-isolate Severe, Critical,
Mild disease +
adherence to quarantine Local monitoring OR Mild disease +
Low Risk*
guidelines and daily team to ensure High Risk
monitoring adherence to
quarantine
guidelines and daily ISOLATE ISOLATE
monitoring
Isolation may be in a Isolation SHOULD
non-health facility BE in a health
*Low risk: <60 years old, NO comorbidity,, NOT a high risk
pregnancy, NOT a health worker vs a health facility facility
Epidemiology Bureau
04/13/2020 73
RECOVERED
• Clinically
improved/recovered
Recovered Clinically
Improved/Recovered*
• At least 1 (-) PCR test
• (+) IgG on RDT
NEGATIVE PCR Test POSITIVE PCR Test
(+) IgG on RDT (-) IgG on RDT Discharge to/Remain in

an isolation facility (For
cases with POSITIVE PCR
Discharge from test) to undergo 14-day
Discharge to/Remain in an isolation
isolation facility monitoring
facility (For cases with NEGATIVE
PCR test) to undergo 14-day
Tag as “Recovered” Repeat PCR at end of 14
monitoring
Repeat RDT at end of 14 days. Follow days. Follow algorithm
algorithm above as per RDT result. above as per PCR test
result.
*Stable clinical status with marked improvement or resolution of signs and symptoms
Epidemiology Bureau
04/13/2020 74

Covid 19 Notifiable PIDsr PDF

Încărcat de

Informații document

Titlu original

Drepturi de autor

Formate disponibile

Partajați acest document

Partajați sau inserați document

Opțiuni de partajare

Vi se pare util acest document?

Este necorespunzător acest conținut?

Drepturi de autor:

Formate disponibile

Covid 19 Notifiable PIDsr PDF

Încărcat de

Drepturi de autor:

Formate disponibile

AO 2020-0013

Revision to AO 2020-0012 Listing

April 13, 2020

*Included in Joint AO between DOH and DILG

• by tracing the contacts of infected individuals, testing them for

• Simultaneously, infected individuals have a recognized right to medical

• Public health teams typically disclose the minimum amount of

Note: Public health officials have recognized that the goals of

Local Government Unit

• Members: City or Municipal Philippine National Police; physicians, nurses, midwives,

DOH- Contact Tracing Team

Should ideally be in a Did not fit COVID-19 Fit COVID-19 Case

NEGATIVE PCR Test POSITIVE PCR Test

(+) IgG on RDT (-) IgG on RDT Discharge to/Remain in

S-ar putea să vă placă și